Tempers flared Tuesday on Capitol Hill as senators from both parties unleashed blistering criticism of pharmacy benefit managers, accusing them of profiteering, monopolistic practices, and systematically forcing independent pharmacies out of business.
Originally designed to help lower drug costs by negotiating discounts with manufacturers, PBMs have come under fire from lawmakers, doctors, pharmacists, and patients who argue they drive prices up by pocketing hidden rebates, steering patients to their own affiliated pharmacies, and reimbursing independent pharmacies at unsustainable rates.
The majority of the hostility during the Senate Judiciary Committee meeting was directed at JC Scott, the president and chief executive officer of the Pharmaceutical Care Management Association, which represents America’s PBMs.
Trending: JUST IN: Roberts Rebukes Liberal Justice For Interrupting Birthright Citizenship Hearing
Sen. Josh Hawley (R-MO) accused Scott and the PBM industry of enriching themselves while patients
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!